BioCentury
ARTICLE | Company News

Matrix license with MRC

April 17, 2001 7:00 AM UTC

The U.K. Medical Research Council (London, U.K.) granted Matrix Therapeutics (Nottingham, U.K.) exclusive global development and marketing rights to technology for the diagnosis of human papilloma vir...